ANTIGENIC ANALYSIS OF BORDETELLA-PERTUSSIS FILAMENTOUS HEMAGGLUTININ WITH PHAGE DISPLAY LIBRARIES AND RABBIT ANTI-FILAMENTOUS HEMAGGLUTININPOLYCLONAL ANTIBODIES
Dr. Wilson et al., ANTIGENIC ANALYSIS OF BORDETELLA-PERTUSSIS FILAMENTOUS HEMAGGLUTININ WITH PHAGE DISPLAY LIBRARIES AND RABBIT ANTI-FILAMENTOUS HEMAGGLUTININPOLYCLONAL ANTIBODIES, Infection and immunity, 66(10), 1998, pp. 4884-4894
Although substantial advancements have been made in the development of
efficacious acellular vaccines against Bordetella pertussis, continue
d progress requires better understanding of the antigenic makeup of B.
pertussis virulence factors, including filamentous hemagglutinin (FNA
). To identify antigenic regions of FHA, phage display libraries const
ructed by using random fragments of the 10-kbp EcoRI fragment of B. pe
rtussis fhaB were affinity selected with rabbit anti-FHA polyclonal an
tibodies. Characterization of antibody-reactive clones displaying FHA-
derived peptides identified 14 antigenic regions, each containing one
or more epitopes. A number of clones mapped within regions containing
known or putative FHA adhesin domains and may be relevant for the gene
ration of protective antibodies. The immunogenic potential of the phag
e-displayed peptides was assessed indirectly by comparing their recogn
ition by antibodies elicited by sodium dodecyl sulfate (SDS)-denatured
and native FHA and by measuring the inhibition of this recognition by
purified FHA. FHA residues 1929 to 2019 may contain the most dominant
linear epitope of FHA. Clones mapping to this region accounted for ca
. 20% of clones recovered from the initial library selection and scree
ning procedures. They are strongly recognized by sera against both SDS
-denatured and native FNA, and this recognition is readily inhibited b
y purified FHA. Given also that this region includes a factor X homolo
g (J. Sandros and E. Tuomanen, Trends Microbiol. 1:192-196, 1993) and
that the single FHA epitope (residues 2001 to 2015) was unequivocally
defined in a comparable study by E. Leininger et al. (J. Infect. Dis.
175:1423-1431, 1997), peptides derived from residues of 1929 to 2019 o
f FHA are strong candidates for future protection studies.